AXSM

insider transactions

Axsome Therapeutics, Inc. — buys & sells by directors, officers and 10% owners (SEC Form 4).

30D 90D 1Y

Net shares · 30d

-102.0K

0 buy · 102.0K sell

Net value · 30d

-$24.4M

$0 in · $24.4M out

Sentiment · 30d

Net selling

0% buying · 100% selling

Open-market trades · 30d

0 buy · 102.0K sell

Net buy / sell volume

Tap or hover the chart for daily net volume. Green = net buying, red = net selling.

All transactions

Sell·S
Jun 11, 26

Roger Jeffs

Director · 10b5-1

$71.2K

286 sh · $249.12

Own -0%
Sell·S
Jun 10, 26

Susan Mahony

Director · 10b5-1

$73.9K

300 sh · $246.18

Own -27%
Sell·S
Jun 10, 26

Mark Coleman

Director · 10b5-1

$160.1K

643 sh · $249.00

Own -2%
Sell·S
Jun 10, 26

Roger Jeffs

Director · 10b5-1

$70.4K

286 sh · $246.18

Own -0%
Exercise·M
Jun 9, 26

Herriot Tabuteau KEY

Chief Executive Officer · 10b5-1

$0

49.7K sh

Own +100%
Sell·S
Jun 9, 26

Herriot Tabuteau KEY

Chief Executive Officer · 10b5-1

$12.0M

49.7K sh · $241.01

Own -87%
Exercise·M
Jun 9, 26

Herriot Tabuteau KEY

Chief Executive Officer · 10b5-1

$245.9K

49.7K sh · $4.95

Own +687%
Exercise·M
Jun 9, 26

Nick Pizzie KEY

Chief Financial Officer · 10b5-1

$0

33.0K sh

Own +85%
Sell·S
Jun 9, 26

Nick Pizzie KEY

Chief Financial Officer · 10b5-1

$7.9M

33.0K sh · $240.09

Own -43%
Exercise·M
Jun 9, 26

Nick Pizzie KEY

Chief Financial Officer · 10b5-1

$115.5K

33.0K sh · $3.50

Own +77%
Sell·S
Jun 9, 26

Susan Mahony

Director · 10b5-1

$71.2K

300 sh · $237.21

Own -21%
Exercise·M
Jun 8, 26

Roger Jeffs

Director

$0

1.4K sh

Own New
Exercise·M
Jun 8, 26

Roger Jeffs

Director

—

1.4K sh

Own +2%
Exercise·M
Jun 8, 26

Mark E Saad

Director

$0

1.4K sh

Own New
Exercise·M
Jun 8, 26

Mark E Saad

Director

—

1.4K sh

Own +14%
Exercise·M
Jun 8, 26

Susan Mahony

Director · 10b5-1

$0

1.4K sh

Own New
Exercise·M
Jun 8, 26

Susan Mahony

Director · 10b5-1

—

1.4K sh

Own New
Exercise·M
Jun 8, 26

Mark Coleman

Director · 10b5-1

$0

1.4K sh

Own New
Exercise·M
Jun 8, 26

Mark Coleman

Director · 10b5-1

—

1.4K sh

Own +5%
Grant·A
Jun 5, 26

Mark Coleman

Director

$0

1.7K sh

Own New
Grant·A
Jun 5, 26

Susan Mahony

Director

$0

1.7K sh

Own New
Grant·A
Jun 5, 26

Mark E Saad

Director

$0

1.7K sh

Own New
Grant·A
Jun 5, 26

Roger Jeffs

Director

$0

1.7K sh

Own New
Sell·S
Jun 2, 26

Mark Coleman

Director · 10b5-1

$1.2M

5.5K sh · $223.39

Own -16%
Sell·S
Jun 1, 26

Mark Coleman

Director · 10b5-1

$1.4M

6.0K sh · $230.30

Own -15%
Sell·S
May 29, 26

Mark Coleman

Director · 10b5-1

$1.4M

6.0K sh · $233.46

Own -13%

Date▾	Insider	Role	Type	Shares	Own Δ	Price	Value
Jun 11, 2026	Roger Jeffs 10b5-1	Director	Sell S	286	-0%	$249.12	$71.2K
Jun 10, 2026	Susan Mahony 10b5-1	Director	Sell S	300	-27%	$246.18	$73.9K
Jun 10, 2026	Mark Coleman 10b5-1	Director	Sell S	643	-2%	$249.00	$160.1K
Jun 10, 2026	Roger Jeffs 10b5-1	Director	Sell S	286	-0%	$246.18	$70.4K
Jun 9, 2026	Herriot Tabuteau KEY 10b5-1	Chief Executive Officer	Exercise M	49.7K	+100%	—	$0
Jun 9, 2026	Herriot Tabuteau KEY 10b5-1	Chief Executive Officer	Sell S	49.7K	-87%	$241.01	$12.0M
Jun 9, 2026	Herriot Tabuteau KEY 10b5-1	Chief Executive Officer	Exercise M	49.7K	+687%	$4.95	$245.9K
Jun 9, 2026	Nick Pizzie KEY 10b5-1	Chief Financial Officer	Exercise M	33.0K	+85%	—	$0
Jun 9, 2026	Nick Pizzie KEY 10b5-1	Chief Financial Officer	Sell S	33.0K	-43%	$240.09	$7.9M
Jun 9, 2026	Nick Pizzie KEY 10b5-1	Chief Financial Officer	Exercise M	33.0K	+77%	$3.50	$115.5K
Jun 9, 2026	Susan Mahony 10b5-1	Director	Sell S	300	-21%	$237.21	$71.2K
Jun 8, 2026	Roger Jeffs	Director	Exercise M	1.4K	New	—	$0
Jun 8, 2026	Roger Jeffs	Director	Exercise M	1.4K	+2%	—	—
Jun 8, 2026	Mark E Saad	Director	Exercise M	1.4K	New	—	$0
Jun 8, 2026	Mark E Saad	Director	Exercise M	1.4K	+14%	—	—
Jun 8, 2026	Susan Mahony 10b5-1	Director	Exercise M	1.4K	New	—	$0
Jun 8, 2026	Susan Mahony 10b5-1	Director	Exercise M	1.4K	New	—	—
Jun 8, 2026	Mark Coleman 10b5-1	Director	Exercise M	1.4K	New	—	$0
Jun 8, 2026	Mark Coleman 10b5-1	Director	Exercise M	1.4K	+5%	—	—
Jun 5, 2026	Mark Coleman	Director	Grant A	1.7K	New	—	$0
Jun 5, 2026	Susan Mahony	Director	Grant A	1.7K	New	—	$0
Jun 5, 2026	Mark E Saad	Director	Grant A	1.7K	New	—	$0
Jun 5, 2026	Roger Jeffs	Director	Grant A	1.7K	New	—	$0
Jun 2, 2026	Mark Coleman 10b5-1	Director	Sell S	5.5K	-16%	$223.39	$1.2M
Jun 1, 2026	Mark Coleman 10b5-1	Director	Sell S	6.0K	-15%	$230.30	$1.4M
May 29, 2026	Mark Coleman 10b5-1	Director	Sell S	6.0K	-13%	$233.46	$1.4M

About AXSM insider trading

This page tracks insider transactions for Axsome Therapeutics, Inc. (AXSM) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.